Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9248)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2015 (publication date) through Apr 30, 2025
Times Cited of This Article
- Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu YF, Ge FJ, Han B, Yang XQ, Su H, Zhao AC, Zhao MH, Yang YB, Yang J. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. World J Gastroenterol 2015; 21(11): 3256-3265 [PMID: 25805932 DOI: 10.3748/wjg.v21.i11.3256] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i11/3256.htm |
| Number | Citing Articles |
| 1 |
Dongmei Chen, Shudan Liu, Huiming Ma, Xueyun Liang, Haibin Ma, Xiurui Yan, Bao Yang, Jun Wei, Xiaoming Liu. Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0198-9
|
| 2 |
Yan Su, Yu Wang, Yuyan Sun, Xiaodong Zhou. Transcription factor 7 functions as an unfavorable prognostic marker of glioblastoma multiforme by promoting proliferation by upregulating c-Myc. NeuroReport 2018; 29(9): 745 doi: 10.1097/WNR.0000000000001026
|
| 3 |
María Cámara-Quílez, Aida Barreiro-Alonso, Esther Rodríguez-Bemonte, María Quindós-Varela, M. Esperanza Cerdán, Mónica Lamas-Maceiras. Differential Characteristics of HMGB2 Versus HMGB1 and their Perspectives in Ovary and Prostate Cancer. Current Medicinal Chemistry 2020; 27(20): 3271 doi: 10.2174/0929867326666190123120338
|
| 4 |
Zhipeng Li, Jialiang Liu, Tianli Chen, Rongqi Sun, Zengli Liu, Bo Qiu, Yunfei Xu, Zongli Zhang. HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01890-1
|
| 5 |
Yaqing Chen, Dan Liu, Pengfei Liu, Yajing Chen, Huiling Yu, Quan Zhang. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data. Molecular Medicine Reports 2017; 15(3): 1051 doi: 10.3892/mmr.2017.6123
|
| 6 |
Yanbin Wang, Zhaoqiang Jiang, Jianing Yan, Shibo Ying. HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma. Disease Markers 2019; 2019: 1 doi: 10.1155/2019/4183157
|
| 7 |
Liang Tian, Zheng‐Yu Wang, Jun Hao, Xiao‐Yu Zhang. miR‐505 acts as a tumor suppressor in gastric cancer progression through targeting HMGB1. Journal of Cellular Biochemistry 2019; 120(5): 8044 doi: 10.1002/jcb.28082
|
| 8 |
Javier Vaquero, Nathalie Guedj, Audrey Clapéron, Thanh Huong Nguyen Ho-Bouldoires, Valérie Paradis, Laura Fouassier. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. Journal of Hepatology 2017; 66(2): 424 doi: 10.1016/j.jhep.2016.09.010
|
| 9 |
Caixia Fang, Chan Xu, Xiaodong Jia, Xiaoping Li, Chengliang Yin, Xiaojuan Xing, Wenle Li, Zhenyun Wang. Development and validation of a clinical prediction model for the risk of distal metastasis in intrahepatic cholangiocarcinoma: a real-world study. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-023-03084-9
|
| 10 |
Olga Méndez, José Pérez, Jesus Soberino, Fabricio Racca, Javier Cortés, Josep Villanueva. Clinical Implications of Extracellular HMGA1 in Breast Cancer. International Journal of Molecular Sciences 2019; 20(23): 5950 doi: 10.3390/ijms20235950
|
| 11 |
Chunping Cai, Xiaoji Wang, Qiurong Fu, Ai Chen. The VEGF expression associated with prognosis in patients with intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02511-7
|
| 12 |
Simone Brivio, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?. Journal of Clinical Medicine 2015; 4(12): 2028 doi: 10.3390/jcm4121958
|
| 13 |
Mei-yuan Chen, Zi-ping Li, Zhao-na Sun, Ming Ma. USP9X promotes the progression of hepatocellular carcinoma by regulating beta-catenin. Irish Journal of Medical Science (1971 -) 2020; 189(3): 865 doi: 10.1007/s11845-020-02199-2
|
| 14 |
Simone Brivio, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expression 2018; 18(1): 31 doi: 10.3727/105221617X15088670121925
|
| 15 |
Yun‐Fei Xu, Hong‐Da Liu, Zeng‐Li Liu, Chang Pan, Xiao‐Qing Yang, Shang‐Lei Ning, Zong‐Li Zhang, Sen Guo, Jin‐Ming Yu. Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling. Journal of Cellular and Molecular Medicine 2018; 22(11): 5596 doi: 10.1111/jcmm.13833
|
| 16 |
Jinqiang Zhang, Weina Chen, Wenbo Ma, Chang Han, Kyoungsub Song, Hyunjoo Kwon, Tong Wu. EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes. The American Journal of Pathology 2022; 192(12): 1712 doi: 10.1016/j.ajpath.2022.08.008
|
| 17 |
Hui Han, Romain Desert, Sukanta Das, Zhuolun Song, Dipti Athavale, Xiaodong Ge, Natalia Nieto. Danger signals in liver injury and restoration of homeostasis. Journal of Hepatology 2020; 73(4): 933 doi: 10.1016/j.jhep.2020.04.033
|
| 18 |
Changlie Zhang, Zhihong Song, Guangji Yu. High Expression of Parkin Predicts Easier Recurrence of Patients With Adjuvant Transarterial Chemoembolization. Biomarkers in Medicine 2017; 11(10): 823 doi: 10.2217/bmm-2017-0129
|
| 19 |
Yun-Fei Xu, Zeng-Li Liu, Chang Pan, Xiao-Qing Yang, Shang-Lei Ning, Hong-Da Liu, Sen Guo, Jin-Ming Yu, Zong-Li Zhang. HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium. Oncogene 2019; 38(6): 868 doi: 10.1038/s41388-018-0485-8
|
| 20 |
Jiawei Zhang, Qiming Huang, Yi Yang, Jiahui Zhang, Xueting Fang, Yubin Yang, Huifang Liang, Wei Wang, Yanjun Wang. A novel prognostic system combining carbonic anhydrase II and preoperative CA19‐9 for intrahepatic cholangiocarcinoma after curative resection. Cancer 2023; 129(7): 1030 doi: 10.1002/cncr.34639
|
| 21 |
Amirhosein Maharati, Meysam Moghbeli. Role of microRNA-505 during tumor progression and metastasis. Pathology - Research and Practice 2024; 258: 155344 doi: 10.1016/j.prp.2024.155344
|
| 22 |
Su Yeon Lee, Min Kyung Ju, Hyun Min Jeon, Eui Kyong Jeong, Yig Ji Lee, Cho Hee Kim, Hye Gyeong Park, Song Iy Han, Ho Sung Kang, Rodrigo Franco. Regulation of Tumor Progression by Programmed Necrosis. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/3537471
|
| 23 |
Kang-Shuai Li, Xiao-Dong Zhu, Hong-Da Liu, Shi-Zhe Zhang, Xiao-Long Li, Nan Xiao, Xue-Feng Liu, Bin Xu, Ming Lei, Yuan-Yuan Zhang, Wen-Kai Shi, Man-Qing Cao, Yun-Fei Xu, Zhao-You Tang, Hui-Chuan Sun. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma. Cell Death & Disease 2020; 11(5) doi: 10.1038/s41419-020-2549-2
|
| 24 |
Yiyan Qiu, Yang Chen, Tenghui Zeng, Weizhuang Guo, Wenyu Zhou, Xinjian Yang. High‐mobility group box‐B1 (HMGB1) mediates the hypoxia‐induced mesenchymal transition of osteoblast cells via activating ERK/JNK signaling. Cell Biology International 2016; 40(11): 1152 doi: 10.1002/cbin.10616
|
| 25 |
Bo Qiu, Tianli Chen, Rongqi Sun, Zengli Liu, Xiaoming Zhang, Zhipeng Li, Yunfei Xu, Zongli Zhang. Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle. EBioMedicine 2019; 50: 166 doi: 10.1016/j.ebiom.2019.11.021
|
| 26 |
M. Davaadorj, Y. Saito, Y. Morine, T. Ikemoto, S. Imura, C. Takasu, S. Yamada, T. Hiroki, M. Yoshikawa, M. Shimada. Loss of Secreted Frizzled-Related Protein-1 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2017; 43(2): 344 doi: 10.1016/j.ejso.2016.11.017
|
| 27 |
Po-Len Liu, Wei-Lun Liu, Jia-Ming Chang, Yung-Hsiang Chen, Yu-Peng Liu, Hsuan-Fu Kuo, Chong-Chao Hsieh, Yu-Sian Ding, Wei-Wei Chen, Inn-Wen Chong, Aamir Ahmad. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1. PLOS ONE 2017; 12(7): e0180844 doi: 10.1371/journal.pone.0180844
|
| 28 |
Luca Maroni, Marco Marzioni. Diagnosis and Management of Cholangiocarcinoma. 2021; : 555 doi: 10.1007/978-3-030-70936-5_26
|
| 29 |
Kai DU, Xiaoyou WU, Xiaofei JI, Nan LIANG, Zheng LI. Early growth response 1 promoted the invasion of glioblastoma multiforme by elevating HMGB1. Journal of Neurosurgical Sciences 2023; 67(4) doi: 10.23736/S0390-5616.20.05107-3
|
| 30 |
Takashi Murakami, Ryusei Matsuyama, Michio Ueda, Yasuhisa Mochizuki, Yuki Homma, Kunio Kameda, Keiichi Yazawa, Yusuke Izumisawa, Tadao Fukushima, Nobuyuki Kamimukai, Kenichi Yoshida, Noriyuki Kamiya, Robert M. Hoffman, Itaru Endo. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1675-8
|
| 31 |
Xuelian Chen, Lirong Zhang, Yujie Jiang, Lian Song, Yanfang Liu, Fang Cheng, Xin Fan, Xiongfeng Cao, Aihua Gong, Dongqing Wang, Haitao Zhu. Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0726-2
|
| 32 |
Md. Al Amin, Hasna Bouhenni, Mehrukh Zehravi, Sherouk Hussein Sweilam, Trupti Pratik Durgawale, Mohammad Shamim Qureshi, Sumit Durgapal, M. Akiful Haque, Rajeshwar Vodeti, Deepadarshan Urs, Mst Maharunnasa Shatu, Safia Obaidur Rab, Koula Doukani, Talha Bin Emran. Natural compounds and programmed necrosis: pioneering a new frontier in cancer treatments. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-04050-w
|
| 33 |
Yihua Chen, Xuanqiu He, Fang Cheng, Mengqing Li, Xuan Wu, Chi Zhang, Jianfa Li, Bin Huang, Minghua Qi. Angiotensin II promotes EMT of hepatocellular carcinoma cells through high mobility group protein B1 mediated by E4F1. Biochemical and Biophysical Research Communications 2021; 547: 198 doi: 10.1016/j.bbrc.2020.12.107
|
| 34 |
Meiyan Liu, Yang Qu, Xue Teng, Ying Xing, Dandan Li, Chunhong Li, Li Cai. PADI4‑mediated epithelial‑mesenchymal transition in lung cancer cells. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.9968
|
| 35 |
Min Lu, Xinglei Qin, Yajun Zhou, Gang Li, Zhaoyang Liu, Haodi Yue, Xiwen Geng. LncRNA HOTAIR suppresses cell apoptosis, autophagy and induces cell proliferation in cholangiocarcinoma by modulating the miR-204-5p/HMGB1 axis. Biomedicine & Pharmacotherapy 2020; 130: 110566 doi: 10.1016/j.biopha.2020.110566
|
| 36 |
Nattawan Suwannakul, Kaoru Midorikawa, Chunping Du, Ya-Peng Qi, Jie Zhang, Bang-De Xiang, Mariko Murata, Ning Ma. Subcellular localization of HMGB1 in human cholangiocarcinoma: correlation with tumor stage. Discover Oncology 2021; 12(1) doi: 10.1007/s12672-021-00446-1
|